AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
44 hedge funds and large institutions have $17.6M invested in AVEO Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
7% less capital invested
Capital invested by funds: $18.8M → $17.6M (-$1.28M)
8% less funds holding
Funds holding: 48 → 44 (-4)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
43% less call options, than puts
Call options by funds: $28K | Put options by funds: $49K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$381K |
| 2 |
SIM
Spark Investment Management
New York
|
+$152K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$142K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$80.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$794K |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$594K |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$191K |
| 4 |
Renaissance Technologies
New York
|
-$138K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$135K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BWA
51
Burt Wealth Advisors
North Bethesda,
Maryland
| – | -$1K | -130 | Closed |
|
52
Citigroup
New York
| – | +$416 | +35 | New |
|
AVEO Hedge Fund Activity: Q4 2015 in Review
44 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q4 2015, worth a combined $17.6M — down 6.8% from $18.8M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AVEO and 6 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 10 added.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $381K. The largest seller was Granahan Investment Management, exiting entirely with an estimated $794K sold.
- 44 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q4 2015, down from 48 in Q3 2015.
- Funds reported $17.6M of AVEO Pharmaceuticals, Inc. stock for Q4 2015, down 6.8% quarter-over-quarter.
- 6 funds opened new AVEO Pharmaceuticals, Inc. positions in Q4 2015 and 9 closed out, a net change of -3 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q4 2015 was Jacobs Levy Equity Management, an estimated $381K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q4 2015 was Granahan Investment Management, an estimated $794K sold.
Based on aggregated 13F filings for Q4 2015.